3.98
Clearside Biomedical Inc Azioni (CLSD) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
78.88%
0.492
|
2.33 | 0.306 | 1.038 | 0.09 |
| Cost Of Revenue |
100.00%
-
|
0.248 | 0.149 | - | - |
| Gross Profit |
76.37%
0.492
|
2.082 | - | - | - |
|
|
44.28%
4.06
|
7.287 | 7.306 | 6.972 | 7.68 |
| Benefits Costs and Expenses |
49.31%
4.987
|
9.838 | 7.612 | - | - |
| Costs And Expenses |
49.31%
4.987
|
9.838 | 7.612 | 6.972 | 7.68 |
| Operating Income/Loss |
31.45%
-3.568
|
-5.205 | -7.149 | -5.934 | -7.59 |
| Income/Loss From Continuing Operations Before Tax |
40.13%
-4.495
|
-7.508 | -7.306 | 1.038 | -7.595 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.715 | - | - | - |
| Income/Loss From Continuing Operations After Tax |
45.34%
-4.495
|
-8.223 | -7.306 | -7.688 | -7.595 |
|
|
45.34%
-4.495
|
-8.223 | -7.306 | -7.688 | -7.595 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.20%
77.84
|
76.92 | 0.6875 | 74.75 | 74.73 |
| Diluted Average Shares |
1.20%
77.84
|
76.92 | 0.6875 | 74.75 | 74.73 |
| Basic Earnings Per Share |
45.45%
-0.06
|
-0.11 | -0.10 | -0.10 | -0.10 |
| Diluted Earnings Per Share |
45.45%
-0.06
|
-0.11 | -0.10 | -0.10 | -0.10 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):